Bradley Budgen

Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for <i>BCR‐ABL</i> DNA

Paul A. Bartley, David M. Ross, Sarah Latham et al. · International Journal of Laboratory Hematology · 2010 · 56 citations

Sensitive and Specific Measurement of Minimal Residual Disease in Acute Lymphoblastic Leukemia

Alexander A. Morley, Sue Latham, Michael J. Brisco et al. · Journal of Molecular Diagnostics · 2009 · 23 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +11

A DNA Real-Time Quantitative PCR Method Suitable for Routine Monitoring of Low Levels of Minimal Residual Disease in Chronic Myeloid Leukemia

Paul A. Bartley, Susan Latham, Bradley Budgen et al. · Journal of Molecular Diagnostics · 2014 · 23 citations

Hematological Malignancy, Routine Monitoring, Chronic Myeloid Leukemia +13

Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia

Paul A. Bartley, Michael H. Martin‐Harris, Bradley Budgen et al. · British Journal of Haematology · 2010 · 19 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +20

Determining the Repertoire of IGH Gene Rearrangements to Develop Molecular Markers for Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia

Michael J. Brisco, Sue Latham, Rosemary Sutton et al. · Journal of Molecular Diagnostics · 2009 · 12 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Molecular Markers +12